Altered innate immune response in farmers and smokers

Innate Immunity

Volumn 16, Issue 1, 2010, Pages 27-38

  Sahlander, Karin ^a   Larsson, Kjell ^a   Palmberg, Lena ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cigarette smoker; Cytokines; Farmer; Helper T cells; Inflammation; Lipopolysaccharide; Organic dust; Peptidoglycan; Toll like receptors

Indexed keywords

CD14 ANTIGEN; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 14; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ADULT; AGRICULTURAL WORKER; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOKINE RELEASE; DUST EXPOSURE; ENVIRONMENTAL EXPOSURE; EX VIVO STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INNATE IMMUNITY; LONG TERM EXPOSURE; MALE; MONOCYTE; NEUTROPHIL; OCCUPATIONAL EXPOSURE; PIG FARMING; RESPIRATORY TRACT DISEASE; TH2 CELL;

ADULT; AGED; ANTIGENS, CD14; BRONCHIAL PROVOCATION TESTS; BRONCHITIS, CHRONIC; CELLS, CULTURED; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; INTERLEUKIN-13; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NEUTROPHILS; OCCUPATIONAL EXPOSURE; PARTICULATE MATTER; PREVALENCE; SMOKING; TH1 CELLS; TH2 CELLS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

SUIDAE;

EID: 75449114667     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425909106317     Document Type: Article

References (41)

1. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu Rev Immunol 2003 ; 21: 335-376.
2. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006 ; 124: 783-801.
3. Zhiping W., Malmberg P., Larsson BM, Larsson K., Larsson L., Saraf A. Exposure to bacteria in swine-house dust and acute inflammatory reactions in humans. Am J Respir Crit Care Med 1996 ; 154: 1261-1266.
4. Donham KJ, Popendorf W., Palmgren U., Larsson L. Characterization of dusts collected from swine confinement buildings. Am J Ind Med 1986 ; 10: 294-297.
5. Malmberg P., Larsson K. Acute exposure to swine dust causes bronchial hyperresponsiveness in healthy subjects. Eur Respir J 1993 ; 6: 400-404.
6. Larsson KA, Eklund AG, Hansson LO, Isaksson BM, Malmberg PO Swine dust causes intense airways inflammation in healthy subjects. Am J Respir Crit Care Med 1994 ; 150: 973-977.
7. Wang Z., Larsson K., Palmberg L., Malmberg P., Larsson P., Larsson L. Inhalation of swine dust induces cytokine release in the upper and lower airways. Eur Respir J 1997 ; 10: 381-387.
8. Wang Z., Manninen A., Malmberg P., Larsson K. Inhalation of swine-house dust increases the concentrations of interleukin-1 beta (IL-1 beta) and interleukin-1 receptor antagonist (IL-1 ra) in peripheral blood. Respir Med 1998 ; 92: 1022-1027.
9. Fan H., Cook JA Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 2004 ; 10: 71-84.
10. Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 2006 ; 10: 233.
11. Palmberg L., Larsson BM, Malmberg P., Larsson K. Airway responses of healthy farmers and nonfarmers to exposure in a swine confinement building. Scand J Work Environ Health 2002 ; 28: 256-263.
12. Radon K., Danuser B., Iversen M. et al. Respiratory symptoms in European animal farmers. Eur Respir J 2001 ; 17: 747-754.
13. Monso E., Riu E., Radon K. et al. Chronic obstructive pulmonary disease in never-smoking animal farmers working inside confinement buildings. Am J Ind Med 2004 ; 46: 357-362.
14. Iversen M., Dahl R. Working in swine-confinement buildings causes an accelerated decline in FEV1: a 7-yr follow-up of Danish farmers. Eur Respir J 2000 ; 16: 404-408.
15. Hasday JD, Bascom R., Costa JJ, Fitzgerald T., Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999 ; 115: 829-835.
16. Larsson L., Szponar B., Pehrson C. Tobacco smoking increases dramatically air concentrations of endotoxin. Indoor Air 2004 ; 14: 421-424.
17. Droemann D., Goldmann T., Tiedje T., Zabel P., Dalhoff K., Schaaf B. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005 ; 6: 68.
18. Vassallo R., Tamada K., Lau JS, Kroening PR, Chen L. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 2005 ; 175: 2684-2691.
19. Miotto D., Ruggieri MP, Boschetto P. et al. Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis. Eur Respir J 2003 ; 22: 602-608.
20. Cozen W., Diaz-Sanchez D., James Gauderman W. et al. Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption. J Clin Immunol 2004 ; 24: 617-622.
21. Alexis NE, Lay JC, Almond M., Peden DB Inhalation of low-dose endotoxin favors local T(H)2 response and primes airway phagocytes in vivo. J Allergy Clin Immunol 2004 ; 114: 1325-1331.
22. Ferguson GT Recommendations for the management of COPD. Chest 2000 ; 117: 23S - 28S.
23. Larsson K., Tornling G., Gavhed D. et al. Inhalation of cold air increases the number of inflammatory cells in the lungs in healthy subjects. Eur Respir J 1998 ; 12: 825-830.
24. Sundblad BM, von Scheele I., Palmberg L., Olsson M., Larsson K. Repeated exposure to organic material alters inflammation and physiologic airway responses. Eur Respir J 2009 ; In press.
25. Aubry-Damon H., Grenet K., Sall-Ndiaye P. et al. Antimicrobial resistance in commensal flora of pig farmers. Emerg Infect Dis 2004 ; 10: 873-879.
26. Lauener RP, Birchler T., Adamski J. et al. Expression of CD14 and Toll-like receptor 2 in farmersĝ and non-farmersĝ children. Lancet 2002 ; 360: 465-466.
27. LeBouder E., Rey-Nores JE, Rushmere NK et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 2003 ; 171: 6680-6689.
28. Wesselius LJ, Nelson ME, Bailey K., OĝBrien-Ladner AR Rapid lung cytokine accumulation and neutrophil recruitment after lipopolysaccharide inhalation by cigarette smokers and nonsmokers. J Lab Clin Med 1997 ; 129: 106-114.
29. Liew FY, Xu D., Brint EK, OĝNeill LA Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol 2005 ; 5: 446-458.
30. Lang T., Mansell A. The negative regulation of Toll-like receptor and associated pathways. Immunol Cell Biol 2007 ; 85: 425-434.
31. Boone DL, Turer EE, Lee EG et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004 ; 5: 1052-1060.
32. Wertz IE, OĝRourke KM, Zhou H. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004 ; 430: 694-699.
33. Diehl GE, Yue HH, Hsieh K. et al. TRAIL-R as a negative regulator of innate immune cell responses. Immunity 2004 ; 21: 877-889.
34. Mueller T., Terada T., Rosenberg IM, Shibolet O., Podolsky DK Th2 cytokines down-regulate TLR expression and function in human intestinal epithelial cells. J Immunol 2006 ; 176: 5805-5814.
35. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004 ; 202: 175-190.
36. Baumhofer JM, Beinhauer BG, Wang JE et al. Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur J Immunol 1998 ; 28: 610-615.
37. Muchamuel T., Menon S., Pisacane P., Howard MC, Cockayne DA IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. J Immunol 1997 ; 158: 2898-2903.
38. Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 1999 ; 104: 777-785.
39. Wynn TA Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004 ; 4: 583-594.
40. Fichtner-Feigl S., Strober W., Kawakami K., Puri RK, Kitani A. IL-13 signaling through the IL-13 alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 2006 ; 12: 99-106.
41. Rennard SI Chronic obstructive pulmonary disease: linking outcomes and pathobiology of disease modification. Proc Am Thorac Soc 2006 ; 3: 276-280.